Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pulmonary arterial hypertension in connective tissue diseases.

Heart failure clinics - 1 Jul 2012

Mathai Stephen C, Hassoun Paul M

Abstract excerpt

Pulmonary arterial hypertension (PAH) may complicate diverse connective tissue diseases (CTDs). Approximately 10% of patients with systemic sclerosis develop PAH, the prevalence being much lower in other CTDs. However, PAH is an important contributor to morbidity and mortality in all forms of CTD. Despite similarities in presentation, hemodynamic perturbations, and pathogenesis, patients with CTD-associated PAH...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to Hemodynamics
Share to Hypertension, Pulmonary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lupus Erythematosus, Systemic

Share to Prognosis

Share to Protein-Tyrosine Kinases

Share to Scleroderma, Systemic

Share to Time Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 22748903
DOI: 10.1016/j.hfc.2012.04.001
PMCID: PMC3389609

Genes

PAH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pulmonary arterial hypertension in connective tissue diseases.PMID 22748903Read ↗

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.Semantic proximity Read ↗

Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL: Identifying Systemic Sclerosis as a Unique PhenotypeSemantic proximity Read ↗

Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertensionSemantic proximity Read ↗

Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue DiseasesSemantic proximity Read ↗

Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.Semantic proximity Read ↗

Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience.Semantic proximity Read ↗

Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?Semantic proximity Read ↗

Pulmonary hypertension phenotypes in patients with systemic sclerosis.Semantic proximity Read ↗

Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative ‐ Group 3 Pulmonary HypertensionSemantic proximity Read ↗

Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.Semantic proximity Read ↗

Idiopathic pulmonary arterial hypertension.Semantic proximity Read ↗

Cluster analysis reveals three clinical phenotypes of pulmonary artery hypertension associated with connective tissue diseases: insights into inflammation and immunity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.